Leonard G. Gomella, MD, Thomas Jefferson University, Philadelphia, Pennsylvania, discusses the role of genetic testing and the evolving next generation imaging for prostate cancer.

To view slides from Dr. Gomella’s presentation on genetic testing at the 18th Annual Future Directions in Urology Symposium, click here.

To view slides from Dr. Gomella’s presentation on the next generation imaging at the 18th Annual Future Directions in Urology Symposium, click here.

Keywords: prostate cancer, genetic testing, MRI

ABOUT THE AUTHOR

Bernard W. Godwin, Jr. Professor in Prostate Cancer at Thomas Jefferson University |  + posts

Leonard G. Gomella, MD, FACS, completed medical school and general surgery and urology training at the University of Kentucky in Lexington. After a urologic oncology fellowship in the surgery branch of the National Cancer Institute, National Institutes of Health in Bethesda, Maryland. Dr. Gomella is currently the Bernard W. Godwin, Jr. Professor of Prostate Cancer, Chairman of the Department of Urology, Senior Director of Clinical Affairs for the Sidney Kimmel Comprehensive Cancer Center, and the Enterprise VP of Urology at the Jefferson Health System, at Thomas Jefferson University in Philadelphia, Pennsylvania.